Skip to main content
Clinical Trials/NCT04539665
NCT04539665
Unknown
Not Applicable

Extended Mesenteric Excision in Ileocolic Resections for Crohn's Disease: A Multicenter Prospective Cohort Study

Montreal General Hospital2 sites in 1 country30 target enrollmentStarted: September 27, 2019Last updated:

Overview

Phase
Not Applicable
Enrollment
30
Locations
2
Primary Endpoint
Number of participants with endoscopic recurrence at 6 months

Overview

Brief Summary

The study is looking at the role of the mesentery in disease recurrence for ileocolic Crohn's disease. It is a prospective study that has been designed to perform extended mesenteric excision on patients undergoing their first ileocolic resection for Crohn's disease. Endoscopic recurrence will be monitored with the hypothesis that patients receiving extended mesenteric ileocolic resection will have reduced endoscopic recurrence at 6 months after resection.

Detailed Description

The current standard of care for ileocolic Crohn's disease (CD) is a limited mesenteric resection. There is growing, but still limited, evidence that extended mesenteric excision during ileocolic resection is beneficial in decreasing disease recurrence. We propose a prospective multicenter cohort study to better understand the role of extended mesenteric excision in ileocolic CD and how it affects disease recurrence. The primary outcome of this study will be the rate of endoscopic recurrence at 6 months in patients undergoing first-time resection for ileocolic CD. Secondary outcomes will include endoscopic recurrence at 18 months and rates of recurrence requiring surgery by 2 years. These outcomes will be compared to historical controls (limited mesenteric resection). Our hypothesis is that patients receiving extended mesenteric ileocolic resection will have reduced endoscopic recurrence at 6 months after resection. As seen in previous studies, advanced mesenteric and mucosal disease predicts increased surgical recurrence.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • adults \>18 years old
  • diagnosis of CD limited to the distal ileum/ileocolic region
  • no previous ileocolic resection
  • all forms of CD presentation will be included - stricturing, fistulizing, perforating etc.

Exclusion Criteria

  • previous ileocolic resection
  • other sites of CD
  • intraabdominal sepsis

Outcomes

Primary Outcomes

Number of participants with endoscopic recurrence at 6 months

Time Frame: 6 months

Endoscopic recurrence after extended mesenteric ileocolic resection

Secondary Outcomes

  • Rates of post-operative complications compared between study groups(30 days)
  • Number of participants with endoscopic recurrence at 18 months(18 months)
  • Rates of recurrence requiring surgery by 2 years(24 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Sender Liberman MD

Dr. Sender Liberman, Associate Professor of Surgery and Oncology (McGill University), PI

Montreal General Hospital

Study Sites (2)

Loading locations...

Similar Trials